Prof. Dr. med. MPH, Emeritus Heiner Bucher

Xu, Alice X T, Brown, Kevin, Schwartz, Kevin L, Aghlmandi, Soheila, Alderson, Sarah, Brehaut, Jamie C, Brown, Benjamin C, Bucher, Heiner C, Clarkson, Janet, De Sutter, An, Francis, Nick A, Grimshaw, Jeremy, Gunnarsson, Ronny, Hallsworth, Michael, Hemkens, Lars, Høye, Sigurd, Khan, Tasneem, Lecky, Donna M, Leung, Felicia, et al. (2025). Audit and Feedback Interventions for Antibiotic Prescribing in Primary Care: A Systematic Review and Meta-analysis [Journal-article]. Clinical Infectious Diseases, 80(2), 253–262. https://doi.org/10.1093/cid/ciae604

Audige, Annette, Amstutz, Alain, Schuurmans, Mace M., Amico, Patrizia, Braun, Dominique L., Stoeckle, Marcel P., Hasse, Barbara, Hage, Rene, Damm, Dominik, Tamm, Michael, Mueller, Nicolas J., Gunthard, Huldrych F., Koller, Michael T., Schonenberger, Christof M., Griessbach, Alexandra, Labhardt, Niklaus D., Kouyos, Roger D., Trkola, Alexandra, Huber, Michael, et al. (2025). Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function. PLoS ONE, 20(1 January). https://doi.org/10.1371/journal.pone.0317965

Amstutz, Alain, Chammartin, Frédérique, Audigé, Annette, Eichenberger, Anna L, Braun, Dominique L, Amico, Patrizia, Stoeckle, Marcel P, Hasse, Barbara, Papadimitriou-Olivgeris, Matthaios, Manuel, Oriol, Bongard, Cédric, Schuurmans, Macé M, Hage, René, Damm, Dominik, Tamm, Michael, Mueller, Nicolas J, Rauch, Andri, Günthard, Huldrych F, Koller, Michael T, et al. (2024). Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study [Journal-article]. Journal of Infectious Diseases, 230(4), e847–e859. https://doi.org/10.1093/infdis/jiae291

Aghlmandi, Soheila, Bielicki, Julia, & Bucher, Heiner C. (2024). ‘Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland’ – Author’s reply [Journal-article]. Clinical Microbiology and Infection, 30(7), 967–968. https://doi.org/10.1016/j.cmi.2024.03.030

Chammartin, Frédérique, Mocroft, Amanda, Egle, Alexander, Zangerle, Robert, Smith, Colette, Mussini, Cristina, Wit, Ferdinand, Vehreschild, Jörg Janne, d’Arminio Monforte, Antonella, Castagna, Antonella, Bailly, Laurent, Bogner, Johannes, de Wit, Stéphane, Matulionyte, Raimonda, Law, Matthew, Svedhem, Veronica, Tallada, Joan, Garges, Harmony P, Marongiu, Andrea, et al. (2024). Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus [Journal-article]. Clinical Infectious Diseases, 78(4), 995–1004. https://doi.org/10.1093/cid/ciad671

Aghlmandi, Soheila, Halbeisen, Florian S., Godet, Pascal, Signorell, Andri, Sigrist, Simon, Saccilotto, Ramon, Widmer, Andreas F., Zeller, Andreas, Bielicki, Julia, & Bucher, Heiner C. (2024). Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland [Journal-article]. Clinical Microbiology and Infection, 30(3), 353–359. https://doi.org/10.1016/j.cmi.2023.11.010

Tomonaga, Yuki, de Nijs, Koen, Bucher, Heiner C., de Koning, Harry, & ten Haaf, Kevin. (2024). Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland [Journal-article]. International Journal of Cancer, 154(4), 636–647. https://doi.org/10.1002/ijc.34746

Ouchi D, García-Sangenís A, Moragas A, van der Velden AW, Verheij TJ, Butler CC, Bongard E, Coenen S, Cook J, Francis NA, Godycki-Cwirko M, Lundgren PT, Lionis C, Radzeviciene Jurgute R, Chlabicz S, De Sutter A, Bucher HC, Seifert B, Kovács B, et al. (2022). Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries. Family Practice, 39(3), 398–405. https://doi.org/10.1093/fampra/cmab122

Delabays B, Cavassini M, Damas J, Beuret H, Calmy A, Hasse B, Bucher HC, Frischknecht M, Müller O, Méan M, Vollenweider P, Marques-Vidal P, & Vaucher J. (2022). Cardiovascular risk assessment in people living with HIV compared to the general population. European Journal of Preventive Cardiology, 29(4), 689–699. https://doi.org/10.1093/eurjpc/zwab201

Remera E, Mugwaneza P, Chammartin F., Mulindabigwi A, Musengimana G, Forrest JI, Mwanyumba F, Kondwani N, Condo JU, Riedel DJ, Mills EJ, Nsanzimana S, & Bucher HC. (2021). Towards elimination of mother‐to‐child transmission of HIV in Rwanda: a nested case‐control study of risk factors for transmission. BMC Pregnancy and Childbirth, 21(1). https://doi.org/10.1186/s12884-021-03806-5

Speich B, Chammartin F, Smith D, Stoeckle MP, Amico P, Eichenberger AL, Hasse B, Schuurmans MM, Müller T, Tamm M, Dickenmann M, Abela IA, Trkola A, Hirsch HH, Manuel O, Cavassini M, Hemkens LG, Briel M, Mueller NJ, et al. (2021). A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®. Trials, 22(1), 724. https://doi.org/10.1186/s13063-021-05664-0

Klingenberg R, Aghlmandi S, Räber L, Akhmedov A, Gencer B, Carballo D, Nanchen D, Bucher HC, Rodondi N, Mach F, Windecker S, Landmesser U, von Eckardstein A, Hamm CW, Lüscher TF, & Matter CM. (2021). Cysteine-rich angiogenic inducer 61 improves prognostic accuracy of grace (Global registry of acute coronary events) 2.0 risk score in patients with acute coronary syndromes. Journal of the American Heart Association, 10(20), e020488. https://doi.org/10.1161/jaha.120.020488

Greenberg L, Ryom L, Neesgaard B, Wandeler G, Staub T, Gisinger M, Skoll M, Günthard HF, Scherrer A, Mussini C, Smith C, Johnson M, De Wit S, Necsoi C, Pradier C, Wit F, Lehmann C, d’Arminio Monforte A, Miró JM, et al. (2021). Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living with Human Immunodeficiency Virus. Clinical Infectious Diseases, 73(7), E2323–E2333. https://doi.org/10.1093/cid/ciaa1878

Kappos EA, Schulz A, Regan MM, Moffa G, Harder Y, Ribi K, Potter S, Pusic AL, Fehr MK, Hemkens LG, Holzbach T, Farhadi J, Simonson C, Knauer M, Verstappen R, Bucher HC, Zwahlen D, Zimmermann F, Schwenkglenks M, et al. (2021). Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): A pragmatic, multicentre, randomised, superiority trial. BMJ Open, 11(9), e045239. https://doi.org/10.1136/bmjopen-2020-045239

Glinz D, Georg Hansen J, Trutmann C, Schaller B, Vogt J, Diermayr C, Marti A, Leitmeyer K, Doerig P, Zeller A, Welge-Luessen Lemcke A, & Bucher HC. (2021). Single-use device endoscopy for the diagnosis of acute bacterial rhinosinusitis in primary care: A pilot and feasibility study. Clinical Otolaryngology, 46(5), 1050–1056. https://doi.org/10.1111/coa.13785

Stuart B, Maund E, Wilcox C, Sridharan K, Sivaramakrishnan G, Regas C, Newell D, Soulsby I, Tang KF, Finlay AY, Bucher HC, Little P, Layton AM, & Santer M. (2021). Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis*. British Journal of Dermatology, 185(3), 512–525. https://doi.org/10.1111/bjd.20080

Venekamp RP, Hoogland J, van Smeden M, Rovers MM, De Sutter AI, Merenstein D, van Essen GA, Kaiser L, Liira H, Little P, Bucher HC, & Reitsma JB. (2021). Identifying adults with acute rhinosinusitis in primary care that benefit most from antibiotics: Protocol of an individual patient data meta-analysis using multivariable risk prediction modelling. BMJ Open, 11(7), e047186. https://doi.org/10.1136/bmjopen-2020-047186

Chammartin F, Lodi S., Logan R., Ryom L, Mocroft A., Kirk O., d’Arminio Monforte A, Reiss P., Phillips A., El-Sadr W, Hatleberg CI, Pradier C, Bonnet F, Law M, De Wit S, Sabin C., Lundgren J.D., Bucher HC, D:A:D Study Group, et al. (2021). Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study. Annals of Internal Medicine, 174(6), 768–776. https://doi.org/10.7326/m20-5226

Kaech M, Deutschmann E., Moffa G., Haak F., Bucher HC, Kettelhack C, & von Strauss Und Torney M. (2021). Influence of the introduction of caseload requirements on indication for visceral cancer surgery in Switzerland. European Journal of Surgical Oncology, 47(6), 1324–1331. https://doi.org/10.1016/j.ejso.2021.04.006

Stuart B, Hounkpatin H, Becque T, Yao G, Zhu S, Alonso-Coello P, Altiner A, Arroll B, Böhning D, Bostock J, Bucher HC, Chao J, de la Poza M, Francis N, Gillespie D, Hay AD, Kenealy T, Löffler C, McCormick DP, et al. (2021). Delayed antibiotic prescribing for respiratory tract infections: Individual patient data meta-analysis. The BMJ, 373, n808. https://doi.org/10.1136/bmj.n808

Audigé, Laurent, Bucher, Heiner C.C., Aghlmandi, Soheila, Stojanov, Thomas, Schwappach, David, Hunziker, Sabina, Candrian, Christian, Cunningham, Gregory, Durchholz, Holger, Eid, Karim, Flury, Matthias, Jost, Bernhard, Lädermann, Alexandre, Moor, Beat Kaspar, Moroder, Philipp, Rosso, Claudio, Schär, Michael, Scheibel, Markus, Spormann, Christophe, et al. (2021). Swiss-wide multicentre evaluation and prediction of core outcomes in arthroscopic rotator cuff repair: Protocol for the ARCR_Pred cohort study. BMJ Open, 11(4). https://doi.org/10.1136/bmjopen-2020-045702

The RESPOND study group. (2021). The interrelationship of smoking, CD4+cell count, viral load and cancer in persons living with HIV. Aids, 35(5), 747–757. https://doi.org/10.1097/qad.0000000000002791

Glinz D, Mc Cord KA, Moffa G, Aghlmandi S, Saccilotto R, Zeller A, Widmer AF, Bielicki J, Kronenberg A, & Bucher HC. (2021). Antibiotic prescription monitoring and feedback in primary care in Switzerland: Design and rationale of a nationwide pragmatic randomized controlled trial. Contemporary Clinical Trials Communications, 21, 100712. https://doi.org/10.1016/j.conctc.2021.100712

Klingenberg R, Aghlmandi S, Gencer B, Nanchen D, Räber L, Carballo D, Carballo S, Stähli BE, Landmesser U, Rodondi N, Mach F, Windecker S, Bucher HC, von Eckardstein A, Lüscher TF, & Matter CM. (2021). Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events. Atherosclerosis, 320, 31–37. https://doi.org/10.1016/j.atherosclerosis.2021.01.012

Zens Y, Barth M, Bucher HC, Dreck K, Felsch M, Groß W, Jaschinski T, Kölsch H, Kromp M, Overesch I, Sauerland S, & Gregor S. (2020). Negative pressure wound therapy in patients with wounds healing by secondary intention: A systematic review and meta-analysis of randomised controlled trials. Systematic Reviews, 9(1), 238. https://doi.org/10.1186/s13643-020-01476-6

Kronlage, Cornelius, Hardmeier, Martin, Bally, Seraina, Scholz, Marleen Carina, Bucher, Heiner C, Müller, Olivia Katharina, Winterhalder, Clemens, Mongiat, Michel, Müller, Jannis, Polymeris, Alexandros, Weber, Martin, Lausberg, Christina, Kassi, Elianne, Kuhle, Jens, Kappos, Ludwig, Hermann, Wieland, Bernsmeier, Christine, & Yaldizli, Özgür. (2020). Muscle stiffness, gait instability, and liver cirrhosis in Wilson’s disease. The Lancet, 396(10256), 990. https://doi.org/10.1016/S0140-6736(20)31963-2

d’Arminio Monforte A, Bonnet F, Bucher HC, Pourcher V, Pantazis N, Pelchen-Matthews A, Touloumi G, & Wolf E. (2020). What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohorts. HIV Medicine, 21(S2), 3–16. https://doi.org/10.1111/hiv.12935

Gryaznov D, Chammartin F., Stoeckle M., Anagnostopoulos A., Braun DL, Furrer H., Boillat-Blanco N, Bernasconi E., Schmid P, Nordmann A., & Bucher HC. (2020). Smartphone App and Carbon Monoxide Self-Monitoring Support for Smoking Cessation: A Randomized Controlled Trial Nested into the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 85(1), E8–E11. https://doi.org/10.1097/qai.0000000000002396

Dell-Kuster S, Gomes NV, Gawria L, Aghlmandi S, Aduse-Poku M, Bissett I, Blanc C, Brandt C, Ten Broek RB, Bruppacher HR, Clancy C, Delrio P, Espin E, Galanos-Demiris K, Gecim IE, Ghaffari S, Gié O, Goebel B, Hahnloser D, et al. (2020). Prospective validation of classification of intraoperative adverse events (ClassIntra): international, multicentre cohort study. The BMJ, 370, m2917. https://doi.org/10.1136/bmj.m2917

Nsanzimana S, Mills EJ, Harari O, Mugwaneza P, Karita E, Uwizihiwe JP, Park JJ, Dron L, Condo J, Bucher H, & Thorlund K. (2020). Prevalence and incidence of HIV among female sex workers and their clients: Modelling the potential effects of intervention in Rwanda. BMJ Global Health, 5(8). https://doi.org/10.1136/bmjgh-2020-002300

Weber WP, Morrow M, Boniface J, Pusic A, Montagna G, Kappos EA, Ritter M, Haug M, Kurzeder C, Saccilotto R, Schulz A., Benson J, Fitzal F, Matrai Z, Shaw J, Peeters MV, Potter S, Heil J, Oncoplastic Breast Consortium., & Oncoplastic Breast Consortium. (2020). Knowledge gaps in oncoplastic breast surgery. The Lancet Oncology, 21(8), e375–e385. https://doi.org/10.1016/s1470-2045(20)30084-x

Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, Cook J, Francis NA, Lewis RJ, Godycki-Cwirko M, Llor C, Chlabicz S, Lionis C, Seifert B, Sundvall PD, Colliers A, Aabenhus R, Bjerrum L, Jonassen Harbin N, et al. (2020). Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. The Lancet, 395(10217), 42–52. https://doi.org/10.1016/s0140-6736(19)32982-4

Ladanie, Aviv, Schmitt, Andreas M., Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V., Sclafani, Francesco, Herbrand, Amanda K., Briel, Matthias, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P. A., Bucher, Heiner C., Kasenda, Benjamin, & Hemkens, Lars G. (2020). Clinical trial evidence supporting US Food and Drug Administration approval of novel cancer therapies between 2000 and 2016. Jama Network Open, 3(11), e2024406. https://doi.org/10.1001/jamanetworkopen.2020.24406

von Strauss und Torney, Marco, Moffa, Giusi, Kaech, Max, Haak, Fabian, Riss, Stefan, Deutschmann, Elisabeth, Bucher, Heiner C., Kettelhack, Christoph, & Paterson, Hugh M. (2020). Risk of Emergency Surgery or Death After Initial Nonoperative Management of Complicated Diverticulitis in Scotland and Switzerland. JAMA Surgery, 155(7), 600–606. https://doi.org/10.1001/jamasurg.2020.0757

Bachmann, Nadine, von Siebenthal, Chantal, Vongrad, Valentina, Turk, Teja, Neumann, Kathrin, Beerenwinkel, Niko, Bogojeska, Jasmina, Fellay, Jaques, Roth, Volker, Kok, Yik Lim, Thorball, Christian W., Borghesi, Alessandro, Parbhoo, Sonali, Wieser, Mario, Böni, Jürg, Perreau, Matthieu, Klimkait, Thomas, Yerly, Sabine, Battegay, Manuel, et al. (2019). Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART. Nature Communications, 10(1). https://doi.org/10.1038/s41467-019-10884-9

Courlet, Perrine, Livio, Françoise, Guidi, Monia, Cavassini, Matthias, Battegay, Manuel, Stoeckle, Marcel, Buclin, Thierry, Saldanha, Susana Alves, Csajka, Chantal, Marzolini, C., Decosterd, Laurent, Anagnostopoulos, A., Battegay, M., Bernasconi, E., Böni, J., Braun, D.L., Bucher, H.C., Calmy, A., Cavassini, M., et al. (2019). Polypharmacy, drug–drug interactions, and inappropriate drugs: New challenges in the aging population with HIV. Open Forum Infectious Diseases, 6(12). https://doi.org/10.1093/ofid/ofz531

Lodi S, Günthard HF, Gill J, Phillips AN, Dunn D, Vu Q, Siemieniuk R, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Reiss P, van Sighem A, Boender TS, Porter K, Gilson R, Paraskevis D, Simeon M, et al. (2019). Effectiveness of Transmitted Drug Resistance Testing before Initiation of Antiretroviral Therapy in HIV-Positive Individuals. Journal of Acquired Immune Deficiency Syndromes, 82(3), 314–320. https://doi.org/10.1097/qai.0000000000002135

Surial B, Cavassini M, Calmy A, Fehr J, Stöckle M, Bernasconi E, Roth B, Fux CA, Kovari H, Furrer H, Rauch A, Wandeler G, & Swiss HIV Cohort Study. (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC Infectious Diseases, 19(1), 834. https://doi.org/10.1186/s12879-019-4454-9

Andreas C., Jaled C., Johannes T H., Lukas E., Laura W., Andri R., Hansjakob F., Andreas M., Uyen H.-D., Spyridon A., Nicolas J M., Matthias C., Matteo M., Christian V.D., Thomas F., Xavier M., Catherine B.-A., Amico P., Aubert J.-D., et al. (2019). Imaging patterns of pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients - A multicentre study. Swiss Medical Weekly, 149(39-40). https://doi.org/10.4414/smw.2019.20130

Kernen P, Steveling-Klein EH, Saccilotto RT, Raatz H, Briel M, Koller MT, Westwood M, Bucher HC, Miedinger D, & Leuppi JD. (2019). The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: A systematic review. Swiss Medical Weekly, 149(35-36), w20100. https://doi.org/10.4414/smw.2019.20100

Barcelo C., Aouri M., Courlet P., Guidi M., Braun D.L., Gunthard H.F., Piso R.J., Cavassini M., Buclin T., Decosterd L.A., Csajka C., Anagnostopoulos A., Battegay M., Bernasconi E., Boni J., Braun D.L., Bucher H.C., Calmy A., Cavassini M., et al. (2019). Population pharmacokinetics of dolutegravir: Influence of drug-drug interactions in a real-life setting. Journal of Antimicrobial Chemotherapy, 74(9), 2690–2697. https://doi.org/10.1093/jac/dkz217

Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, Babiker A, Law M, Chu H, Byrne D, Horban A, Sterne JAC, Porter K, Sabin C, Costagliola D, Abgrall S, Gill J, Touloumi G, Pacheco AG, et al. (2019). Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples with Apples. American Journal of Epidemiology, 188(8), 1569–1577. https://doi.org/10.1093/aje/kwz100

Hachfeld, A., Darling, K., Calmy, A., Ledergerber, B., Weber, R., Battegay, M., Wissel, K., Di Benedetto, C., Fux, C.A., Tarr, P.E., Kouyos, R., Ruggia, L.S., Furrer, H.J., Wandeler, G., Aubert, V., Battegay, M., Bernasconi, E., Böni, J., Braun, D.L., et al. (2019). Why do sub-Saharan Africans present late for HIV care in Switzerland? HIV Medicine, 20(6), 418–423. https://doi.org/10.1111/hiv.12727

Glinz D, Gloy VL, Monsch AU, Kressig RW, Patel C, McCord KA, Ademi Z, Tomonaga Y, Schwenkglenks M, Bucher HC, & Raatz H. (2019). Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer’s disease: A meta-analysis. Swiss Medical Weekly, 149(25-26), w20093. https://doi.org/10.4414/smw.2019.20093

Carlisle L.A., Turk T, Kusejko K, Metzner KJ, Leemann C., Schenkel C.D., Bachmann N, Posada S., Beerenwinkel N., Böni J, Yerly S, Klimkait T, Perreau M, Braun DL, Rauch A, Calmy A, Cavassini M., Battegay M, Vernazza P., et al. (2019). Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection. Journal of Infectious Diseases, 220(2), 254–265. https://doi.org/10.1093/infdis/jiz094

Kusejko K., Bachmann N., Chaudron S.E., Nguyen H., Braun D.L., Hampel B., Battegay M, Bernasconi E, Calmy A., Cavassini M, Hoffmann M, Boni J., Yerly S., Klimkait T, Perreau M., Rauch A., Gunthard H.F., Kouyos R.D., Swiss HIV Cohort Study., et al. (2019). A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 with Coinfections, Noncommunicable Diseases, and Opportunistic Diseases. Journal of Infectious Diseases, 220(2), 244–253. https://doi.org/10.1093/infdis/jiz093

Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, et al. (2019). Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals. Statistics in Medicine, 38(13), 2428–2446. https://doi.org/10.1002/sim.8120

Roethlisberger M, Achermann R, Bawarjan S, Stienen MN, Fung C, D’Alonzo D, Maldaner N, Ferrari A, Corniola MV, Schöni D, Goldberg J, Valsecchi D, Robert T, Maduri R, Seule MA, Burkhardt JK, Marbacher S, Bijlenga P, Blackham KA, et al. (2019). Impact of Aneurysm Multiplicity on Treatment and Outcome after Aneurysmal Subarachnoid Hemorrhage. Clinical Neurosurgery, 84(6), E334–E344. https://doi.org/10.1093/neuros/nyy331

Leon-Reyes S., Schafer J., Fruh M., Schwenkglenks M., Reich O., Schmidlin K., Staehelin C., Battegay M., Cavassini M., Hasse B., Bernasconi E., Calmy A., Hoffmann M., Schoeni-Affolter F., Zhao H., & Bucher H.C. (2019). Cost estimates for Human Immunodeficiency Virus (HIV) care and patient characteristics for health resource use from linkage of claims data with the swiss HIV cohort study. Clinical Infectious Diseases, 68(5), 827–833. https://doi.org/10.1093/cid/ciy564

Braun DL, Hampel B, Martin E, Kouyos R, Kusejko K, Grube C, Flepp M, Stöckle M, Conen A, Béguelin C, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS, & Swiss HIV Cohort Study. (2019). High number of potential transmitters revealed in a population-based systematic hepatitis C Virus RNA screening among human immunodeficiency virus-infected men who have sex with men. Clinical Infectious Diseases, 68(4), 561–568. https://doi.org/10.1093/cid/ciy545

Ladanie, Aviv, Speich, Benjamin, Briel, Matthias, Sclafani, Francesco, Bucher, Heiner C., Agarwal, Arnav, Ioannidis, John P. A., Pereira, Tiago V., Kasenda, Benjamin, & Hemkens, Lars G. (2019). Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies. Journal of Clinical Epidemiology, 114, 49–59. https://doi.org/10.1016/j.jclinepi.2019.05.033

Leon-Reyes, Selene, Schäfer, Juliane, Früh, Mathias, Schwenkglenks, Matthias, Reich, Oliver, Schmidlin, Kurt, Staehelin, Cornelia, Battegay, Manuel, Cavassini, Matthias, Hasse, Barbara, Bernasconi, Enos, Calmy, Alexandra, Hoffmann, Matthias, Schoeni-Affolter, Franziska, Zhao, Hongwei, & Bucher, Heiner C. (2019). Cost estimates for HIV care and patient characteristics for health resource utilisation from linkage of claims data with the Swiss HIV Cohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 68, 827–833. https://doi.org/10.1093/cid/ciy564

Schaefer, Thorsten, Ramadoss, Archana, Leu, Severina, Tintignac, Lionel, Tostado, Cristobal, Bink, Andrea, Schürch, Christoph, Müller, Joëlle, Schärer, Jonas, Moffa, Giusi, Demougin, Philippe, Moes, Suzette, Stippich, Christoph, Falbo, Simona, Neddersen, Heike, Bucher, Heiner, Frank, Stephan, Jenö, Paul, Lengerke, Claudia, et al. (2019). Regulation of Glioma Cell Invasion by 3q26 Gene Products PIK3CA, SOX2 and OPA1. Brain Pathology, 29(3), 336–350. https://doi.org/10.1111/bpa.12670

Stuart B, Hounkpatin H, Becque T, Yao G, Zhu S, Alonso-Coello P, Altiner A, Arroll B, Böhning D, Bostock J, Bucher HCC, de la Poza M, Francis NA, Gillespie D, Hay AD, Kenealy T, Löffler C, Mas-Dalmau G, Muñoz L, et al. (2019). Delayed antibiotic prescribing for respiratory tract infections: Protocol of an individual patient data meta-analysis. BMJ Open, 9(1), e026925. https://doi.org/10.1136/bmjopen-2018-026925

Young J, Scherrer AU, Calmy A, Tarr PE, Bernasconi E, Cavassini M, Hachfeld A, Vernazza P, Günthard HF, Bucher HC, & Swiss HIV Cohort Study. (2019). The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study. Antiviral Therapy, 24(5), 343–353. https://doi.org/10.3851/imp3310

Vach W, Saxer F, Holsgaard-Larsen A, Overgaard S, Farin-Glattacker E, Bless N, Bucher HC, & Jakob M. (2018). Rationale and methods of an observational study to support the design of a nationwide surgical registry: The MIDAS study. Swiss Medical Weekly, 148(45-46), w14680. https://doi.org/10.4414/smw.2018.14680

Sendi, P., Oppliger, N., Chakroun, F., Marinello, C.P., Bucher, H.C., & Bornstein, M.M. (2018). Health State Utilities in Edentulous Patients: A Time Trade-off Approach. JDR Clinical and Translational Research, 3(4), 346–352. https://doi.org/10.1177/2380084418789056

Zumofen DW, Zumofen DW, Roethlisberger M, Achermann R, Bawarjan S, Stienen MN, Fung C, D’Alonzo D, Maldaner N, Ferrari A, Corniola MV, Schoeni D, Goldberg J, Valsecchi D, Robert T, Maduri R, Seule M, Burkhardt JK, Marbacher S, et al. (2018). Factors associated with clinical and radiological status on admission in patients with aneurysmal subarachnoid hemorrhage. Neurosurgical Review, 41(4), 1059–1069. https://doi.org/10.1007/s10143-018-0952-2

Leu S, Boulay JL, Thommen S, Bucher HC, Stippich C, Mariani L, & Bink A. (2018). Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient Survival. World Neurosurgery, 115, e448–e463. https://doi.org/10.1016/j.wneu.2018.04.067

Beguelin C., Suter A., Bernasconi E., Fehr J, Kovari H, Bucher HC, Stoeckle M., Cavassini M., Rougemont M., Schmid P., Wandeler G, Rauch A, Swiss HIV Cohort Study, Battegay M., Boni J., Braun D.L., Calmy A., Ciuffi A., Dollenmaier G., et al. (2018). Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. Liver International, 38(3), 424–431. https://doi.org/10.1111/liv.13528

Stirrup OT, Copas AJ, Phillips AN, Gill MJ, Geskus RB, Touloumi G, Young J, Bucher HC, Babiker AG, & CASCADE Collaboration in EuroCoord. (2018). Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion. HIV Medicine, 19(3), 184–194. https://doi.org/10.1111/hiv.12567

Young, J., Smith, C., Teira, R., Reiss, P., Jarrin Vera, I., Crane, H., Miro, J. M., Monforte, A. D’Arminio, Saag, M., Zangerle, R., & Bucher, H. C. (2018). Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection. HIV Medicine, 19(2), 132–142. https://doi.org/10.1111/hiv.12562

Roethlisberger, Michel, Moffa, Giusi, Fisch, Urs, Wiggli, Benedikt, Schoen, Stephan, Kelly, Christopher, Leu, Severina, Croci, Davide, Zumofen, Daniel W., Cueni, Nadine, Nogarth, Danica, Schulz, Marianne, Bucher, Heiner C., Weisser-Rohacek, Maja, Wasner, Morten-Goetz, Widmer, Andreas F., & Mariani, Luigi. (2018). Effectiveness of a Chlorhexidine Dressing on Silver-coated External Ventricular Drain-associated Colonization and Infection: A Prospective Single-blinded Randomized Controlled Clinical Trial. Clinical Infectious Diseases, 67(12), 1868–1877. https://doi.org/10.1093/cid/ciy393

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Annane D, et al. (2018). Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. The Lancet Infectious Diseases, 18(1), 95–107. https://doi.org/10.1016/S1473-3099(17)30592-3

Odermatt J., Friedli N., Kutz A., Briel M., Bucher H.C., Christ-Crain M., Burkhardt O., Welte T., Mueller B., & Schuetz P. (2017). Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis. Clinical Chemistry and Laboratory Medicine, 56(1), 170–177. https://doi.org/10.1515/cclm-2017-0252

Glinz D, Leon Reyes S, Saccilotto R, Widmer AF, Zeller A, Bucher HC, & Hemkens LG. (2017). Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: A nationwide survey. Journal of Antimicrobial Chemotherapy, 72(11), 3205–3212. https://doi.org/10.1093/jac/dkx278

Lodi, Sara, Costagliola, Dominique, Sabin, Caroline, del Amo, Julia, Logan, Roger, Abgrall, Sophie, Reiss, Peter, van Sighem, Ard, Jose, Sophie, Blanco, Jose-Ramon, Hernando, Victoria, Bucher, Heiner C., Kovari, Helen, Segura, Ferran, Ambrosioni, Juan, Gogos, Charalambos A., Pantazis, Nikos, Dabis, Francois, Vandenhende, Marie-Anne, et al. (2017). Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older. Journal of Acquired Immune Deficiency Syndromes, 76, 311–318. https://doi.org/10.1097/QAI.0000000000001498

Blaser, Nello, Bertisch, Barbara, Calmy, Alexandra, Calmy A., Estill, Janne, Keiser, Olivia, Egger, Matthias, Keiser O., Bucher, Heiner C., Aubert V., Battegay M., Bernasconi E., Boni J., Braun D.L., Bucher H.C., Calmy A., Cavassini M., Ciuffi A., Dollenmaier G., et al. (2017). Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM. Aids, 31(13), 1859–1866. https://doi.org/10.1097/QAD.0000000000001546

Mechera R, Dell-Kuster S, von Strauss Und Torney M, Langer I, Furrer M, Bucher HC, & Rosenthal R. (2017). Tutorial Assistance for Board Certification in Surgery: Frequency, Associated Time and Cost. World Journal of Surgery, 41(8), 1950–1960. https://doi.org/10.1007/s00268-017-3996-5

Odermatt J, Meili M, Hersberger L, Bolliger R, Christ-Crain M, Briel M, Bucher HC, Mueller B, & Schuetz P. (2017). Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: A prospective cohort study. BMC Cardiovascular Disorders, 17(1), 178. https://doi.org/10.1186/s12872-017-0605-3

Negoescu, Diana M., Zhang, Zhenhuan, Bucher, Heiner C., & Bendavid, Eran. (2017). Differentiated human immunodeficiency virus RNA monitoring in resource-limited settings: An economic analysis. Clinical Infectious Diseases, 64(12), 1724–1730. https://doi.org/10.1093/cid/cix177

Caniglia, Ellen C., Cain, Lauren E., Sabin, Caroline A., Robins, James M., Logan, Roger, Abgrall, Sophie, Mugavero, Michael J., Hernandez-Diaz, Sonia, Meyer, Laurence, Seng, Remonie, Drozd, Daniel R., Seage, George R., III, Bonnet, Fabrice, Dabis, Francois, Moore, Richard D., Reiss, Peter, van Sighem, Ard, Mathews, William C., del Amo, Julia, et al. (2017). Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. The Lancet HIV, 4(6), e251–e259. https://doi.org/10.1016/S2352-3018(17)30043-7

Dell-Kuster S, Hoesli I, Lapaire O, Seeberger E, Steiner LA, Bucher HC, & Girard T. (2017). Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial. British Journal of Anaesthesia, 118(5), 772–780. https://doi.org/10.1093/bja/aex034

Rosenthal R, Bucher HC, & Dwan K. (2017). The use of systematic reviews when designing and reporting surgical trials (Patent No. 4). Annals of Surgery, 265(4), Article 4. https://doi.org/10.1097/SLA.0000000000001092

Monge, S., Jarrin, I., Pantazis, N., Mocroft, A., Sabin, C. A., Touloumi, G., van Sighem, A., Abgrall, S., Dray-Spira, R., Spire, B., Castagna, A., Mussini, C., Zangerle, R., Hessamfar, M., Anderson, J., Hamouda, O., Ehren, K., Obel, N., Kirk, O., et al. (2017). Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe. AIDS, 31(6), 835–846. https://doi.org/10.1097/QAD.0000000000001411

Fidler, Sarah, Olson, Ashley D., Bucher, Heiner C., Fox, Julie, Thornhill, John, Morrison, Charles, Muga, Roberto, Phillips, Andrew, Frater, John, & Porter, Kholoud. (2017). Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection. Journal of Acquired Immune Deficiency Syndromes, 74(2), 126–133. https://doi.org/10.1097/QAI.0000000000001220

Hemkens L.G., Saccilotto R., Reyes S.L., Glinz D., Zumbrunn T., Grolimund O., Gloy V., Raatz H., Widmer A., Zeller A., & Bucher H.C. (2017). Personalized prescription feedback using routinely collected data to reduce antibiotic use in primary care a randomized clinical trial. JAMA Internal Medicine, 177(2), 176–183. https://doi.org/10.1001/jamainternmed.2016.8040

Wang, Qing, De Luca, Andrea, Smith, Colette, Zangerle, Robert, Sambatakou, Helen, Bonnet, Fabrice, Smit, Colette, Schommers, Philipp, Thornton, Alicia, Berenguer, Juan, Peters, Lars, Spagnuolo, Vincenzo, Ammassari, Adriana, Antinori, Andrea, Roldan, Eugenia Quiros, Mussini, Cristina, Miro, Jose M., Konopnicki, Deborah, Fehr, Jan, et al. (2017). Chronic hepatitis B and C virus infection and risk for non-hodgkin lymphoma in HIV-infected patients: A cohort study. Annals of Internal Medicine, 166(1), 9–17. https://doi.org/10.7326/M16-0240

Ewald, Hannah, Santini-Oliveira, Marilia, Bühler, Julian-Emanuel, Vuichard, Danielle, Schandelmaier, Stefan, Stöckle, Marcel, Briel, Matthias, Bucher, Heiner C., & Hemkens, Lars G. (2017). Comparative effectiveness of tenofovir in HIV-infected treatment-experienced patients: systematic review and meta-analysis. HIV clinical trials, 18(1), 17–27. https://doi.org/10.1080/15284336.2016.1261073

Petersen, Maya, Logan, Roger, Abgrall, Sophie, Touloumi, Giota, Vourli, Georgia, Vandenhende, Marie-Anne, Reiss, Peter, van Sighem, Ard, Samji, Hasina, Rybniker, Jan, Jose, Sophie, Moreno, Santiago, Cozzi-Lepri, Alessandro, Stephan, Christoph, Jarrin, Inma, Antinori, Andrea, Moore, Richard, Casabona, Jordi, Meyer, Laurence, et al. (2016). Using observational data to emulate a randomized trial of dynamic treatmentswitching strategies: An application to antiretroviral therapy. International Journal of Epidemiology, 45(6), 2038–2049. https://doi.org/10.1093/ije/dyv295

Olson AD, Walker AS, Suthar AB, Sabin C, Bucher HC, Jarrin I, Moreno S, Perez-Hoyos S, Porter K, Ford D, & CASCADE Collaboration in EuroCoord. (2016). Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death. Journal of Acquired Immune Deficiency Syndromes, 73(1), 100–108. https://doi.org/10.1097/qai.0000000000001029

Caniglia EC, Sabin C, Robins JM, Logan R, Cain LE, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RR, Reiss P, van Sighem A, Mathews WC, Del Amo J, et al. (2016). When to monitor CD4 cell count and HIV RNA to reduce mortality and aids-defining illness in virologically suppressed hiv-positive persons on antiretroviral therapy in high-income countries: A prospective observational study (Patent No. 2). Journal of Acquired Immune Deficiency Syndromes, 72(2), Article 2. https://doi.org/10.1097/qai.0000000000000956

Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, et al. (2016). Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS Medicine, 13(6), e1002046. https://doi.org/10.1371/journal.pmed.1002046

De Luca,Andrea, Flandre,Philippe, Dunn,David, Zazzi,Maurizio, Wensing,Annemarie, Santoro,Maria Mercedes, Günthard,Huldrych F, Wittkop,Linda, Kordossis,Theodoros, Garcia,Federico, Castagna,Antonella, Cozzi-Lepri,Alessandro, Churchill,Duncan, De Wit,Stéphane, Brockmeyer,Norbert H, Imaz,Arkaitz, Mussini,Cristina, Obel,Niels, Perno,Carlo Federico, et al. (2016). Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen. Journal of Antimicrobial Chemotherapy, 71(5), 1352–1360. https://doi.org/10.1093/jac/dkv465

Ademi Z, Gloy V, Glinz D, Raatz H, Van Stiphout J, Bucher HC, & Schwenkglenks M. (2016). Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective. Swiss medical weekly, 146, w14382. https://doi.org/10.4414/smw.2016.14382

Aouri,Manel, Barcelo,Catalina, Ternon,Béatrice, Cavassini,Matthias, Anagnostopoulos,Alexia, Yerly,Sabine, Hugues,Henry, Vernazza,Pietro, Günthard,Huldrych F, Buclin,Thierry, Telenti,Amalio, Rotger,Margalida, Decosterd,Laurent A, & Swiss HIV Cohort Study. (2016). In vivo profiling and distribution of known and novel phase i and phase II metabolites of efavirenz in plasma, urine, and cerebrospinal fluid. Drug Metabolism and Disposition, 44(1), 151–161. https://doi.org/10.1124/dmd.115.065839

Bucher, Heiner C, Achermann, Rita, Stohler, Nadja, & Meier, Christoph R. (2016). Surveillance of physicians causing potential drug-drug interactions in ambulatory care: A pilot study in Switzerland. PLoS ONE, 11(1). https://doi.org/10.1371/journal.pone.0147606

Mocroft,Amanda, Lundgren,Jens D, Ross,Michael, Fux,Christoph A, Reiss,Peter, Moranne,Olivier, Morlat,Philippe, Monforte,Antonella d’Arminio, Kirk,Ole, Ryom,Lene, & Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. (2016). Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study. The Lancet HIV, 3(1), e23–e32. https://doi.org/10.1016/S2352-3018(15)00211-8

Schandelmaier S., Von Elm E., You J.J., Blumle A., Tomonaga Y., Lamontagne F., Saccilotto R., Amstutz A., Bengough T., Meerpohl J.J., Stegert M., Olu K.K., Tikkinen K.A.O., Neumann I., Carrasco-Labra A., Faulhaber M., Mulla S.M., Mertz D., Akl E.A., et al. (2016). Premature discontinuation of randomized trials in critical and emergency care: A retrospective cohort study. Critical Care Medicine, 44(1), 130–137. https://doi.org/10.1097/CCM.0000000000001369

Young J, Moodie EE, Abrahamowicz M, Klein MB, Weber R, & Bucher HC. (2015). Incomplete Modeling of the Effect of Antiretroviral Therapy on the Risk of Cardiovascular Events (Patent No. 7). Clinical Infectious Diseases, 61(7), Article 7. https://doi.org/10.1093/cid/civ515

Young J., Rickenbach M, Calmy A., Bernasconi E., Staehelin C., Schmid P, Cavassini M, Battegay M, Gunthard H.F., Bucher HC, Aubert V., Battegay M., Bernasconi E., Boni J., Bucher H.C., Burton-Jeangros C., Calmy A., Cavassini M., Dollenmaier G., et al. (2015). Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study. BMC Infectious Diseases, 15(1). https://doi.org/10.1186/s12879-015-1120-8

Dell-Kuster S, Clavien PA, Bucher HC, & Rosenthal R. (2015). Classification of Intraoperative Complications: Reply (Patent No. 12). World Journal of Surgery, 39(12), Article 12. https://doi.org/10.1007/s00268-015-3199-x

Lodi S., Phillips A., Logan R., Olson A., Costagliola D., Abgrall S., van Sighem A., Reiss P., Miró J.M., Ferrer E., Justice A., Gandhi N., Bucher H.C., Furrer H., Moreno S., Monge S., Touloumi G., Pantazis N., Sterne J., et al. (2015). Comparative eff ectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: Observational cohort study. The Lancet HIV, 2(8), e335–e343. https://doi.org/10.1016/S2352-3018(15)00108-3

Rosenthal R., von Websky, M. W., Hoffmann H., Vitz, M., Hahnloser D., Bucher, H. C., & Schafer J. (2015). How to report multiple outcome metrics in virtual reality simulation. European Surgery - Acta Chirurgica Austriaca, 47(4), 202–205. https://doi.org/10.1007/s10353-015-0327-7

Rosenthal R, Hoffmann H, Clavien PA, Bucher HC, & Dell-Kuster S. (2015). Definition and classification of intraoperative complications (classic): Delphi study and pilot evaluation. World Journal of Surgery, 39(7), 1663–1671. https://doi.org/10.1007/s00268-015-3003-y

Rohner A, Ried K, Sobenin IA, Bucher HC, & Nordmann AJ. (2015). A systematic review and metaanalysis on the effects of garlic preparations on blood pressure in individuals with hypertension. American Journal of Hypertension, 28(3), 414–423. https://doi.org/10.1093/ajh/hpu165

Gueler,Aysel, Schoeni-Affolter,Franziska, Moser,André, Bertisch,Barbara, Bucher,Heiner C, Bucher,Heiner C, Calmy,Alexandra, Cavassini,Matthias, Ledergerber,Bruno, Wandeler,Gilles, Egger,Matthias, & Swiss HIV Cohort Study Swiss National Cohort. (2015). Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland. AIDS, 29(2), 231–238. https://doi.org/10.1097/qad.0000000000000524

Hemkens, Lars G., Ewald, Hannah, Santini-Oliveira, Marilia, Bühler, Julian-Emanuel, Vuichard, Danielle, Schandelmaier, Stefan, Stöckle, Marcel, Briel, Matthias, & Bucher, Heiner C. (2015). Comparative effectiveness of tenofovir in treatment-näive HIV-infected patients: Systematic review and meta-analysis. HIV Clinical Trials, 16(5), 178–189. https://doi.org/10.1179/1945577115y.0000000004

Wandeler G, Schlauri M, Jaquier ME, Rohrbach J, Metzner KJ, Fehr J, Ambrosioni J, Cavassini M, Stöckle M, Schmid P, Bernasconi E, Keiser O, Salazar-Vizcaya L, Furrer H, Rauch A, Swiss HIV Cohort Study, Aubert V, Battegay M, Bernasconi E, et al. (2015). Incident hepatitis C virus infections in the Swiss HIV Cohort Study: Changes in treatment uptake and outcomes between 1991 and 2013. Open Forum Infectious Diseases, 2(1), ofv026. https://doi.org/10.1093/ofid/ofv026

Young,Jim, Xiao,Yongling, Moodie,Erica E M, Abrahamowicz,Michal, Klein,Marina B, Bernasconi,Enos, Schmid,Patrick, Calmy,Alexandra, Cavassini,Matthias, Cusini,Alexia, Weber,Rainer, Bucher,Heiner C, Bucher,Heiner C, & Swiss HIV Cohort Study. (2015). Effect of cumulating exposure to abacavir on the risk of cardiovascular disease events in patients from the swiss HIV cohort study. Journal of Acquired Immune Deficiency Syndromes, 69(4), 413–421. https://doi.org/10.1097/qai.0000000000000662